A detailed history of Axiom Investors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Axiom Investors LLC holds 12,914 shares of UTHR stock, worth $4.06 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,914
Previous 8,635 49.55%
Holding current value
$4.06 Million
Previous $1.9 Million 56.27%
% of portfolio
0.03%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$210.76 - $249.51 $901,842 - $1.07 Million
4,279 Added 49.55%
12,914 $2.97 Million
Q4 2023

Feb 12, 2024

BUY
$214.88 - $256.94 $904,644 - $1.08 Million
4,210 Added 95.14%
8,635 $1.9 Million
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $260,326 - $305,086
1,229 Added 38.45%
4,425 $999,000
Q2 2023

Aug 10, 2023

SELL
$205.19 - $232.99 $46,578 - $52,888
-227 Reduced 6.63%
3,196 $705,000
Q1 2023

May 12, 2023

SELL
$212.99 - $276.17 $222,148 - $288,045
-1,043 Reduced 23.35%
3,423 $766,000
Q4 2022

Feb 09, 2023

SELL
$205.95 - $280.43 $6,796 - $9,254
-33 Reduced 0.73%
4,466 $1.24 Million
Q3 2022

Nov 10, 2022

SELL
$203.3 - $244.17 $838,002 - $1.01 Million
-4,122 Reduced 47.81%
4,499 $942,000
Q2 2022

Aug 11, 2022

BUY
$174.81 - $241.14 $358,710 - $494,819
2,052 Added 31.24%
8,621 $2.03 Million
Q1 2022

May 13, 2022

SELL
$166.16 - $213.96 $1.67 Million - $2.15 Million
-10,029 Reduced 60.42%
6,569 $1.18 Million
Q4 2021

Feb 11, 2022

BUY
$184.32 - $216.08 $993,116 - $1.16 Million
5,388 Added 48.06%
16,598 $3.59 Million
Q3 2021

Nov 12, 2021

SELL
$179.86 - $214.88 $2.5 Million - $2.99 Million
-13,912 Reduced 55.38%
11,210 $2.07 Million
Q2 2021

Aug 13, 2021

BUY
$170.47 - $211.93 $733,021 - $911,299
4,300 Added 20.65%
25,122 $4.51 Million
Q1 2021

May 14, 2021

BUY
$153.94 - $174.85 $3.21 Million - $3.64 Million
20,822 New
20,822 $3.48 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Axiom Investors LLC Portfolio

Follow Axiom Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investors LLC with notifications on news.